Andrew Geall

Andrew Geall

Company: Replicate Bioscience

Job title: Co-founder & Chief Development Officer

Seminars:

Chair’s Closing Remarks 4:00 pm

Read more

day: Day Two

Panel Discussion: Discussing Emerging LNP Modifications & Polymer-Based RNA Delivery for Next Generation RNA Therapeutics 2:30 pm

Outlining the advantages of different LNP modifications to enhance target specificity of next generation RNA therapeutics Describing the biological mechanism of LNP and polymer-based delivery to increase target specificity Discussing the challenges of maintaining sufficient extrahepatic protein expressionRead more

day: Day Two

Chair’s Opening Remarks 8:50 am

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.